Development of new therapy for airway goblet cell metaplasia by transition to ciliated cells
Project/Area Number |
18590867
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Tokyo Women's Medical University |
Principal Investigator |
KONDO Mitsuko Tokyo Women's Medical University, School of Medicine, Senior Lecturer (50178430)
|
Project Period (FY) |
2006 – 2007
|
Project Status |
Completed (Fiscal Year 2007)
|
Budget Amount *help |
¥3,920,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥420,000)
Fiscal Year 2007: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2006: ¥2,100,000 (Direct Cost: ¥2,100,000)
|
Keywords | goblet cell / ciliated cell / interleukin-13 / mucin / cell transition / asthma / remodeling / インターロイキン13 / 細胞転換 |
Research Abstract |
1. In vitro study using highly differentiated epithelial cell culture. Interleukin (IL)-13 induces goblet cell metaplasia and plays an important role in mucus hypersecretion in asthma. In this study, we asked whether elimination of IL-13 could reverse the established goblet cell metaplasia into ciliated epithelia. Primary epithelial cells from guinea pig tracheas were cultured at an air-liquid interface with the medium containing human recombinant IL-13 for 14 days, and continuously cultured with IL-13-eliminated medium, or cultured under the condition of neutralization of IL-13 with anti IL-13 antibody. After 2 days from elimination of IL-13, PAS-positive area as well as MUC5AC protein level rapidly decreased. After 4 days, the number of goblet cells dramatically decreased, while that of ciliated cells inversely increased. Total number of epithelial cells did not change, and 5-bromo-2'-deoxyuridine uptake decreased after IL-13 elimination. Transitional cells with cilia and secretory granules increased after IL-13 elimination. Similarly, the neutralization of IL-13 with anti IL-13 antibody for 5 days reversed the goblet cell metaplasia into ciliated epithelia, and transitional cells also increased. 2. In vivo study using remodeled airway in sensitized guinea pigs. Airway goblet cell metaplasia was obtained by repeated ovalbumin sensitization in guinea pigs, and the effects of Th2 inhibitor, anti IL-13 antibody and steroid on goblet cell metaplasia were investigated.,Tracheas were removed and stained with PAS/alcian blue. Mucus area was assessed by computer image analysis. As a result, mucus area was suppressed by the inhibitors, and transitional cells with both cilia and mucus granules appeared. 3. Anti IL-13 therapy may reverse goblet cell metaplasia into ciliated epithelia. Transition of goblet cells to ciliated cells is provably involved in this phenomenon. Anti IL-13 therapy may be a therapeutic strategy of established goblet cell metaplasia in asthma.
|
Report
(3 results)
Research Products
(24 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Elimination of IL-13 reverses established goblet cell metaplasia into ciliated epithelia in airway epithelial cell culture2006
Author(s)
Kondo, M., Tamaoki, J., Takeyama, K., Isono, K., Kawatani, K., Izumo, T., Nagai, A
-
Journal Title
Allergol Int 33
Pages: 329-36
NAID
Description
「研究成果報告書概要(欧文)」より
Related Report
-
-
-
-
-
-
-
-
-
-